tiprankstipranks
bluebird bio (BLUE)
NASDAQ:BLUE
US Market

Bluebird Bio Income Statement

Last quarter (Q3 2024), Bluebird Bio's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Bluebird Bio's net income was $-60.81M. See Bluebird Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ -4.03M$ -6.48M$ -35.20M$ -559.26M$ 41.70M
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 28.52M$ 4.90M$ 4.90M$ 5.10M$ 13.40M
EBITDA
$ -167.13M$ -277.15M$ -545.46M$ -539.90M$ -772.72M
Operating Income
$ -244.26M$ -287.09M$ -590.91M$ -559.26M$ -814.83M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -211.91M$ -266.58M$ -819.38M$ -618.70M$ -789.61M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Bluebird Bio Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis